ARCHIVES

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985